Neutral impactIPO

Paras Healthcare shares to list today: Check GMP ahead of debut

Economic Times 1 hr ago·28 Oct 2026, 2:43 am

Paras Healthcare is set to make its market debut today, marking a significant milestone for the healthcare sector. The company raised Rs 1,450 crore through its IPO, which included a fresh issue of shares and an offer for sale by existing shareholders. This listing will provide liquidity to early investors and open a new avenue for retail participation in the company's growth story.

For investors, the listing offers an opportunity to evaluate the stock's market valuation against its fundamentals. The company's performance post-listing will be closely watched to gauge investor sentiment and its potential to deliver long-term value in the competitive healthcare landscape.

Investors should monitor the opening price and trading volume today to assess market reception. Key factors to watch include the stock's ability to hold its ground and any announcements regarding future business expansion or strategic initiatives.

Excerpt from Economic Times

The Rs 1,450-crore IPO comprised a fresh issue of 72.15 lakh shares worth Rs 500 crore and an offer for sale (OFS) of 1.37 crore shares aggregating to Rs 950 crore. The company fixed the price band at Rs 660–693 per share, with a lot size of 21 shares. At the upper end of the price band, retail investors applying for…
Read the original at Economic Times

Affected stocks

Neutral1 stock

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

  • Concerns Paras Healthcare (PARASHLTH).
  • Category: IPO.
  • Assessed as a significant, market-relevant update.

Why it matters

A meaningful update for Paras Healthcare worth tracking. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at Economic Times.

More IPO news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.